| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |